Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
15,705,504
-
Share change
-
+4,053,042
-
Total reported value
-
$219,397,678
-
Price per share
-
$13.97
-
Number of holders
-
63
-
Value change
-
+$56,766,148
-
Number of buys
-
43
-
Number of sells
-
20
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2017
As of 30 Jun 2017,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,705,504 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, MPM ASSET MANAGEMENT LLC, BlackRock Inc., FMR LLC, JENNISON ASSOCIATES LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, and ORBIMED ADVISORS LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.